Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $34

PROCEPT BioRobotics Corp. +4.82%

PROCEPT BioRobotics Corp.

PRCT

24.59

+4.82%

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ: PRCT) with a Overweight and lowers the price target from $51 to $34.